| 8/23/2006 | CV | Kerzner sets merger conversion price for 2.375% convertibles, announces change of control tender
|
| 8/4/2006 | BKCVHY | S&P: Kerzner International remains on watch
|
| 3/21/2006 | CV | Market Commentary: BioMarin comes in ahead of new issue; Casual Male seen as cheap; Vista delay could mean tech troubles
|
| 3/20/2006 | BKCVHY | Moody's may downgrade Kerzner
|
| 3/20/2006 | CV | Market Commentary: Kerzner buyout hurts hedge investors; BioMarin plans new deal; Time Warner Telecom offer seen as cheap
|
| 3/20/2006 | BKCVHY | Kerzner to get new credit facility, notes for buyout led by management, to tender for existing notes
|
| 3/20/2006 | BKCVHY | S&P puts Kerzner on negative watch
|
| 9/15/2005 | BKCVHY | S&P gives Kerzner notes B
|
| 9/15/2005 | BKCVHY | Moody's assigns Kerzner notes B2
|
| 12/13/2004 | CV | Market Commentary: Nextel higher on Sprint talks; Kerzner slides amid 'trouble in Paradise'; NRG deal appears
|
| 8/10/2004 | CV | Market Commentary: Six Flags hit by outlook; Charter steady; Delta drifts lower; Trump news stirs sellers in casino paper
|
| 6/24/2004 | BKCVHY | S&P downgrades Kerzner
|
| 6/4/2004 | CV | Market Commentary: Mandalay Bay mounts 11.5-point gain, lifts all casino paper; Computer Associates applauded
|
| 5/4/2004 | BKCVDDHY | S&P may cut Kerzner
|
| 4/21/2004 | CV | Kerzner greenshoe exercised, raising convertibles to $230 million
|
| 4/5/2004 | CV | Market Commentary: Financial Federal bid 100.5 in gray market; Decode Genetics emerges; gaming paper on fire
|
| 4/1/2004 | CV | Market Commentary: Massey at 101.25 in gray market; UnitedGlobalCom's euro convert trades down to 99; retailers routed
|
| 4/1/2004 | BKCVHY | S&P rates Kerzner converts B+
|
| 3/31/2004 | CV | New Issue: Kerzner upsized $200 million convertible yields 2.375%, up 33%
|
| 3/31/2004 | CV | Market Commentary: Amylin at 102 bid before pricing aggressively; Caesars dips below par; Kerzner bets push past 101
|
| 3/30/2004 | CV | Kerzner $150 million convertible talked at 2.125-2.625%, up 30-35%
|
| 3/30/2004 | CV | Market Commentary: Caesars, Kerzner, Impax Labs on tap with FelCor, Regal-Beloit; ON Semicon, Amylin launched
|
